p2xFlag CMV2-YAP2 Citations (25)
Originally described in: Mst2 and Lats kinases regulate apoptotic function of YAP.Oka T, Mazack V, Sudol M J Biol Chem. 2008 Jul 17. ():. PubMed Journal
Articles Citing p2xFlag CMV2-YAP2
| Articles |
|---|
| Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor. Paramasivam M, Sarkeshik A, Yates JR 3rd, Fernandes MJ, McCollum D. Mol Biol Cell. 2011 Oct;22(19):3725-33. doi: 10.1091/mbc.E11-04-0300. Epub 2011 Aug 10. PubMed |
| LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap. Nguyen HB, Babcock JT, Wells CD, Quilliam LA. Oncogene. 2013 Aug 29;32(35):4100-9. doi: 10.1038/onc.2012.431. Epub 2012 Oct 1. PubMed |
| Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins. Reddy BV, Irvine KD. Dev Cell. 2013 Mar 11;24(5):459-71. doi: 10.1016/j.devcel.2013.01.020. PubMed |
| Amot130 adapts atrophin-1 interacting protein 4 to inhibit yes-associated protein signaling and cell growth. Adler JJ, Heller BL, Bringman LR, Ranahan WP, Cocklin RR, Goebl MG, Oh M, Lim HS, Ingham RJ, Wells CD. J Biol Chem. 2013 May 24;288(21):15181-93. doi: 10.1074/jbc.M112.446534. Epub 2013 Apr 5. PubMed |
| Control of the hippo pathway by Set7-dependent methylation of Yap. Oudhoff MJ, Freeman SA, Couzens AL, Antignano F, Kuznetsova E, Min PH, Northrop JP, Lehnertz B, Barsyte-Lovejoy D, Vedadi M, Arrowsmith CH, Nishina H, Gold MR, Rossi FM, Gingras AC, Zaph C. Dev Cell. 2013 Jul 29;26(2):188-94. doi: 10.1016/j.devcel.2013.05.025. Epub 2013 Jul 11. PubMed |
| Organ size control is dominant over Rb family inactivation to restrict proliferation in vivo. Ehmer U, Zmoos AF, Auerbach RK, Vaka D, Butte AJ, Kay MA, Sage J. Cell Rep. 2014 Jul 24;8(2):371-81. doi: 10.1016/j.celrep.2014.06.025. Epub 2014 Jul 10. PubMed |
| Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex. Liang N, Zhang C, Dill P, Panasyuk G, Pion D, Koka V, Gallazzini M, Olson EN, Lam H, Henske EP, Dong Z, Apte U, Pallet N, Johnson RL, Terzi F, Kwiatkowski DJ, Scoazec JY, Martignoni G, Pende M. J Exp Med. 2014 Oct 20;211(11):2249-63. doi: 10.1084/jem.20140341. Epub 2014 Oct 6. PubMed |
| The human adenovirus type 5 E4orf4 protein targets two phosphatase regulators of the Hippo signaling pathway. Mui MZ, Zhou Y, Blanchette P, Chughtai N, Knight JF, Gruosso T, Papadakis AI, Huang S, Park M, Gingras AC, Branton PE. J Virol. 2015 Jun 17. pii: JVI.03710-14. PubMed |
| Hippo signaling is required for Notch-dependent smooth muscle differentiation of neural crest. Manderfield LJ, Aghajanian H, Engleka KA, Lim LY, Liu F, Jain R, Li L, Olson EN, Epstein JA. Development. 2015 Sep 1;142(17):2962-71. doi: 10.1242/dev.125807. Epub 2015 Aug 7. PubMed |
| Transformation by Polyomavirus Middle T Antigen Involves A Unique Bimodal Interaction with the Hippo Effector YAP. Rouleau C, Pores Fernando AT, Hwang JH, Faure N, Jiang T, White EA, Roberts TM, Schaffhausen BS. J Virol. 2016 May 18. pii: JVI.00417-16. PubMed |
An in vivo transfection system for inducible gene expression and gene silencing in murine hepatocytes.
Hubner EK, Lechler C, Kohnke-Ertel B, Zmoos AF, Sage J, Schmid RM, Ehmer U.
J Gene Med. 2016 Dec 23. doi: 10.1002/jgm.2940.
PubMed
Associated Plasmids |
| YAP1 regulates prostate cancer stem cell-like characteristics to promote castration resistant growth. Jiang N, Ke B, Hjort-Jensen K, Iglesias-Gato D, Wang Z, Chang P, Zhao Y, Niu X, Wu T, Peng B, Jiang M, Li X, Shang Z, Wang Q, Chang C, Flores-Morales A, Niu Y. Oncotarget. 2017 Dec 7;8(70):115054-115067. doi: 10.18632/oncotarget.23014. eCollection 2017 Dec 29. PubMed |
| Dishevelled has a YAP nuclear export function in a tumor suppressor context-dependent manner. Lee Y, Kim NH, Cho ES, Yang JH, Cha YH, Kang HE, Yun JS, Cho SB, Lee SH, Paclikova P, Radaszkiewicz TW, Bryja V, Kang CG, Yuk YS, Cha SY, Kim SY, Kim HS, Yook JI. Nat Commun. 2018 Jun 12;9(1):2301. doi: 10.1038/s41467-018-04757-w. PubMed |
| Caveolin-1 Modulates Mechanotransduction Responses to Substrate Stiffness through Actin-Dependent Control of YAP. Moreno-Vicente R, Pavon DM, Martin-Padura I, Catala-Montoro M, Diez-Sanchez A, Quilez-Alvarez A, Lopez JA, Sanchez-Alvarez M, Vazquez J, Strippoli R, Del Pozo MA. Cell Rep. 2018 Nov 6;25(6):1622-1635.e6. doi: 10.1016/j.celrep.2018.10.024. PubMed |
| The Hippo Pathway Prevents YAP/TAZ-Driven Hypertranscription and Controls Neural Progenitor Number. Lavado A, Park JY, Pare J, Finkelstein D, Pan H, Xu B, Fan Y, Kumar RP, Neale G, Kwak YD, McKinnon PJ, Johnson RL, Cao X. Dev Cell. 2018 Dec 3;47(5):576-591.e8. doi: 10.1016/j.devcel.2018.09.021. Epub 2018 Oct 25. PubMed |
| Src-mediated crosstalk between FXR and YAP protects against renal fibrosis. Kim DH, Choi HI, Park JS, Kim CS, Bae EH, Ma SK, Kim SW. FASEB J. 2019 Oct;33(10):11109-11122. doi: 10.1096/fj.201900325R. Epub 2019 Jul 12. PubMed |
| PR55alpha regulatory subunit of PP2A inhibits the MOB1/LATS cascade and activates YAP in pancreatic cancer cells. Hein AL, Brandquist ND, Ouellette CY, Seshacharyulu P, Enke CA, Ouellette MM, Batra SK, Yan Y. Oncogenesis. 2019 Oct 28;8(11):63. doi: 10.1038/s41389-019-0172-9. PubMed |
| Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway. Kurppa KJ, Liu Y, To C, Zhang T, Fan M, Vajdi A, Knelson EH, Xie Y, Lim K, Cejas P, Portell A, Lizotte PH, Ficarro SB, Li S, Chen T, Haikala HM, Wang H, Bahcall M, Gao Y, Shalhout S, Boettcher S, Shin BH, Thai T, Wilkens MK, Tillgren ML, Mushajiang M, Xu M, Choi J, Bertram AA, Ebert BL, Beroukhim R, Bandopadhayay P, Awad MM, Gokhale PC, Kirschmeier PT, Marto JA, Camargo FD, Haq R, Paweletz CP, Wong KK, Barbie DA, Long HW, Gray NS, Janne PA. Cancer Cell. 2020 Jan 13;37(1):104-122.e12. doi: 10.1016/j.ccell.2019.12.006. PubMed |
| Vinexin contributes to autophagic decline in brain ageing across species. Park SJ, Frake RA, Karabiyik C, Son SM, Siddiqi FH, Bento CF, Sterk P, Vicinanza M, Pavel M, Rubinsztein DC. Cell Death Differ. 2022 May;29(5):1055-1070. doi: 10.1038/s41418-021-00903-y. Epub 2021 Nov 30. PubMed |
| Mechanical control of nuclear import by Importin-7 is regulated by its dominant cargo YAP. Garcia-Garcia M, Sanchez-Perales S, Jarabo P, Calvo E, Huyton T, Fu L, Ng SC, Sotodosos-Alonso L, Vazquez J, Casas-Tinto S, Gorlich D, Echarri A, Del Pozo MA. Nat Commun. 2022 Mar 4;13(1):1174. doi: 10.1038/s41467-022-28693-y. PubMed |
| Impaired degradation of YAP1 and IL6ST by chaperone-mediated autophagy promotes proliferation and migration of normal and hepatocellular carcinoma cells. Desideri E, Castelli S, Dorard C, Toifl S, Grazi GL, Ciriolo MR, Baccarini M. Autophagy. 2023 Jan;19(1):152-162. doi: 10.1080/15548627.2022.2063004. Epub 2022 Apr 18. PubMed |
| RBFOX2-regulated TEAD1 alternative splicing plays a pivotal role in Hippo-YAP signaling. Choi S, Lee HS, Cho N, Kim I, Cheon S, Park C, Kim EM, Kim W, Kim KK. Nucleic Acids Res. 2022 Aug 26;50(15):8658-8673. doi: 10.1093/nar/gkac509. PubMed |
| Epithelial-mesenchymal reprogramming by KLF4-regulated Rictor expression contributes to metastasis of non-small cell lung cancer cells. Zhou H, Guan Q, Hou X, Liu L, Zhou L, Li W, Liu H. Int J Biol Sci. 2022 Jul 18;18(13):4869-4883. doi: 10.7150/ijbs.73548. eCollection 2022. PubMed |
| Mitochondrial stress induces AREG expression and epigenomic remodeling through c-JUN and YAP-mediated enhancer activation. Hino Y, Nagaoka K, Oki S, Etoh K, Hino S, Nakao M. Nucleic Acids Res. 2022 Sep 23;50(17):9765-9779. doi: 10.1093/nar/gkac735. PubMed |
| The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells. Slaninova V, Heron-Milhavet L, Robin M, Jeanson L, Aissanou A, Kantar D, Tosi D, Brehelin L, Gongora C, Djiane A. BMC Cancer. 2024 May 14;24(1):587. doi: 10.1186/s12885-024-12316-4. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.